Deshi Dong

1.6k total citations
58 papers, 1.2k citations indexed

About

Deshi Dong is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Deshi Dong has authored 58 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 17 papers in Oncology and 11 papers in Epidemiology. Recurrent topics in Deshi Dong's work include Pancreatic and Hepatic Oncology Research (8 papers), Liver Disease Diagnosis and Treatment (8 papers) and Genomics, phytochemicals, and oxidative stress (4 papers). Deshi Dong is often cited by papers focused on Pancreatic and Hepatic Oncology Research (8 papers), Liver Disease Diagnosis and Treatment (8 papers) and Genomics, phytochemicals, and oxidative stress (4 papers). Deshi Dong collaborates with scholars based in China. Deshi Dong's co-authors include Yan Qi, Jinyong Peng, Lianhong Yin, Lina Xu, Hong Xiang, Fangyue Guo, Youwei Xu, Linlin Lv, Xu Han and Shilei Yang and has published in prestigious journals such as Food Chemistry, Journal of Pharmacology and Experimental Therapeutics and Frontiers in Immunology.

In The Last Decade

Deshi Dong

53 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deshi Dong China 19 518 209 164 159 119 58 1.2k
Rufeng Ma China 16 657 1.3× 202 1.0× 104 0.6× 159 1.0× 115 1.0× 24 1.3k
Zhiyong Li China 14 637 1.2× 311 1.5× 124 0.8× 144 0.9× 147 1.2× 48 1.4k
Zhijun Wang China 22 562 1.1× 190 0.9× 105 0.6× 176 1.1× 116 1.0× 76 1.6k
Yun-Ping Lim Taiwan 23 444 0.9× 290 1.4× 125 0.8× 132 0.8× 182 1.5× 61 1.2k
Laila A. Eissa Egypt 22 399 0.8× 214 1.0× 236 1.4× 81 0.5× 87 0.7× 54 1.1k
Xuelin Zhou China 22 648 1.3× 396 1.9× 145 0.9× 174 1.1× 114 1.0× 94 1.4k
Guo Yu China 23 577 1.1× 177 0.8× 74 0.5× 128 0.8× 200 1.7× 97 1.5k
Zeng-Chun Ma China 23 680 1.3× 390 1.9× 116 0.7× 112 0.7× 131 1.1× 89 1.3k
Jiangzheng Liu China 19 575 1.1× 122 0.6× 161 1.0× 98 0.6× 67 0.6× 35 1.1k

Countries citing papers authored by Deshi Dong

Since Specialization
Citations

This map shows the geographic impact of Deshi Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deshi Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deshi Dong more than expected).

Fields of papers citing papers by Deshi Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deshi Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deshi Dong. The network helps show where Deshi Dong may publish in the future.

Co-authorship network of co-authors of Deshi Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Deshi Dong. A scholar is included among the top collaborators of Deshi Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deshi Dong. Deshi Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zuo, Yufang, Shilei Yang, Xufeng Tao, et al.. (2025). Contribution and expression of renal drug transporters in renal cell carcinoma. Frontiers in Pharmacology. 15. 1466877–1466877. 3 indexed citations
2.
Dong, Deshi, et al.. (2025). Research progress and future perspectives of prodrug strategies for immune checkpoint inhibitors in cancer immunotherapy. Critical Reviews in Oncology/Hematology. 214. 104905–104905.
3.
Jiao, Yang, et al.. (2025). Examining the Impact of Microglia on Ischemic Stroke With an Emphasis on the Metabolism of Immune Cells. CNS Neuroscience & Therapeutics. 31(2). e70229–e70229. 5 indexed citations
4.
5.
6.
Guo, Fangyue, Xufeng Tao, Yu Wu, et al.. (2024). Carfilzomib relieves pancreatitis-initiated pancreatic ductal adenocarcinoma by inhibiting high-temperature requirement protein A1. Cell Death Discovery. 10(1). 58–58.
7.
Tao, Xufeng, Xiaohan Zhai, Zirui Zhao, et al.. (2023). Naringin against doxorubicin‐induced hepatotoxicity in mice through reducing oxidative stress, inflammation, and apoptosis via the up‐regulation of SIRT1. Environmental Toxicology. 38(5). 1153–1161. 22 indexed citations
8.
Zhai, Xiaohan, Xufeng Tao, Shilei Yang, et al.. (2023). Success stories of natural product-derived compounds from plants as multidrug resistance modulators in microorganisms. RSC Advances. 13(12). 7798–7817. 14 indexed citations
9.
10.
Zhou, Qi, Xufeng Tao, Fangyue Guo, et al.. (2023). Tryptophan metabolite norharman secreted by cultivated Lactobacillus attenuates acute pancreatitis as an antagonist of histone deacetylases. BMC Medicine. 21(1). 329–329. 18 indexed citations
11.
Tao, Xufeng, Xiaohan Zhai, Yanna Zhu, et al.. (2023). Application of aptamer-drug delivery system in the therapy of breast cancer. Biomedicine & Pharmacotherapy. 161. 114444–114444. 42 indexed citations
12.
13.
Xiang, Hong, et al.. (2022). Contemporary Chinese dietary pattern: Where are the hidden risks?. Frontiers in Nutrition. 9. 997773–997773. 11 indexed citations
14.
Xiang, Hong, et al.. (2022). Metabolic reprogramming of immune cells in pancreatic cancer progression. Biomedicine & Pharmacotherapy. 157. 113992–113992. 42 indexed citations
15.
Lv, Linlin, Yanna Zhu, Xiaohan Zhai, et al.. (2022). Relationship between metabolic reprogramming and drug resistance in breast cancer. Frontiers in Oncology. 12. 942064–942064. 25 indexed citations
16.
Xiang, Hong, et al.. (2020). What we already know about rhubarb: a comprehensive review. Chinese Medicine. 15(1). 88–88. 124 indexed citations
17.
Dong, Deshi, et al.. (2020). <p>Cetuximab Plus Chemotherapy versus Chemotherapy Alone in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Cost-Effectiveness Analysis</p>. Cancer Management and Research. Volume 12. 11383–11390. 10 indexed citations
18.
Dong, Deshi, et al.. (2020). Pembrolizumab vs the EXTREME Regimen in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Cost-Effectiveness Analysis. Clinical Drug Investigation. 40(12). 1137–1146. 11 indexed citations
19.
Dong, Deshi, Shuai Zhang, Lianhong Yin, et al.. (2013). Protective effects of the total saponins from Rosa laevigata Michx fruit against carbon tetrachloride-induced acute liver injury in mice. Food and Chemical Toxicology. 62. 120–130. 55 indexed citations
20.
Zhang, Shuai, Lingli Zheng, Deshi Dong, et al.. (2013). Effects of flavonoids from Rosa laevigata Michx fruit against high-fat diet-induced non-alcoholic fatty liver disease in rats. Food Chemistry. 141(3). 2108–2116. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rufeng Ma Breakdown of academic impact, for papers by Zhiyong Li Breakdown of academic impact, for papers by Zhijun Wang Breakdown of academic impact, for papers by Yun-Ping Lim Breakdown of academic impact, for papers by Laila A. Eissa Breakdown of academic impact, for papers by Xuelin Zhou Breakdown of academic impact, for papers by Guo Yu Breakdown of academic impact, for papers by Zeng-Chun Ma Breakdown of academic impact, for papers by Jiangzheng Liu
Rankless by CCL
2026